Nantahala Capital Management, LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
133
Total Value
2187261798
Accession Number
0001104659-25-049574
Form Type
13F-HR
Manager Name
Nantahala Capital Management, LLC
Data Enrichment
90% identified
120 identified13 unidentified

Holdings

133 positions
Manager:
Search and click to pin securities to the top
Vistagen Therapeutics, Inc.
Shares:
1978492(-0.2%)
Value:
$4.9B(-15.4%)
NOODLES & Co
Shares:
4505489(-0.1%)
Value:
$4.9B(+88.2%)
ALTA EQUIPMENT GROUP INC.
Shares:
1042769(+23.4%)
Value:
$4.9B(-11.5%)
Xencor Inc
Shares:
456741
Value:
$4.9B
Fossil Group, Inc.
Shares:
4189177(+25.9%)
Value:
$4.8B(-13.3%)
Inhibikase Therapeutics, Inc.
Shares:
2190000(+0.0%)
Value:
$4.8B(-32.6%)
RumbleOn, Inc.
Shares:
1700000(+0.0%)
Value:
$4.8B(-48.1%)
CARGO Therapeutics, Inc.
Shares:
1100000
Value:
$4.5B
Apyx Medical Corp
Shares:
3258048(+2.8%)
Value:
$4.5B(-10.9%)
ROCKET PHARMACEUTICALS, INC.
Shares:
629749
Value:
$4.2B
Tango Therapeutics, Inc.
Shares:
2987983(+6.5%)
Value:
$4.1B(-52.8%)
Anebulo Pharmaceuticals, Inc.
Shares:
3036325(+0.0%)
Value:
$3.9B(-22.6%)
Kosmos Energy Ltd.
Shares:
1716593
Value:
$3.9B
Eledon Pharmaceuticals, Inc.
Shares:
1141237(-0.6%)
Value:
$3.9B(-18.2%)
Akebia Therapeutics, Inc.
Shares:
2000000
Value:
$3.8B
NeuroPace Inc
Shares:
312094(-44.5%)
Value:
$3.8B(-39.0%)
Rezolute, Inc.
Shares:
1291395(-54.8%)
Value:
$3.7B(-73.3%)
Upstream Bio, Inc.
Shares:
594971(-0.8%)
Value:
$3.6B(-63.1%)
Dyne Therapeutics, Inc.
Shares:
345062
Value:
$3.6B
Astria Therapeutics, Inc.
Shares:
669530(-0.8%)
Value:
$3.6B(-40.8%)